Post-Market Study of Alcon Intraocular Lenses
Launched by ALCON RESEARCH · Jun 8, 2022
Trial Information
Current as of June 14, 2025
Completed
Keywords
ClinConnect Summary
This observational study will enroll subjects who have been implanted with an Alcon aspheric monofocal or monofocal toric IOL no less than 4 months prior to study procedures. This study will be conducted in Australia.
Gender
ALL
Eligibility criteria
- Key Inclusion Criteria:
- • In good general health at the screening visit;
- • Implanted in both eyes at least 4 months ago with either Vivity/Vivity toric IOL or an Alcon aspheric monofocal/monofocal toric IOL (Acrysof IQ/Clareon);
- • Best Corrected Distance Visual Acuity (BCDVA) of 20/25 or better with both eyes together;
- • BCDVA of 20/40 or better in each eye;
- Key Exclusion Criteria:
- • Clinically significant Posterior Capsular Opacity (PCO) as assessed via slit-lamp exam per investigator opinion;
- • History of ocular surgery other than cataract surgery and Nd:YAG laser surgery;
- • History of amblyopia.
About Alcon Research
Alcon Research is a leading global company dedicated to advancing eye care through innovative research and development. As a subsidiary of Novartis, Alcon focuses on the development of cutting-edge products and therapies for vision correction and eye health, including surgical, pharmaceutical, and consumer eye care solutions. With a commitment to enhancing the quality of life for patients worldwide, Alcon Research conducts rigorous clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of care. Through collaboration with healthcare professionals and institutions, Alcon remains at the forefront of ophthalmic advancements, driving progress in the field of vision science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kelvin Grove, Queensland, Australia
Patients applied
Trial Officials
Director of Clinical Projects, Surgical
Study Director
Alcon Research, LLC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials